Delivery Order SPE2DB22D2206-SPE2DB25FJS42
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,048.25 for Zepbound 10 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Zepbound 15 mg/0.5 ml pen injectors with a ceiling value of $20,970.99. This is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $9,527.57 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injectors on August 1, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and is scheduled for completion by August 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $3,431.61 on August 21, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's larger relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections, valued at $5,504.59. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 28, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $6,518.07 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order executed under an existing contract vehicle and requires fulfillment within an...
- The Defense Logistics Agency awarded a $11,592.37 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 11, 2025. This is a non-set-aside, competitively awarded contract with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors valued at $3,349.68 under a firm fixed price contract. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical distributor will...
- The Defense Logistics Agency awarded a $1,143.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by July 22, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors valued at $6,100.68. This firm fixed-price, non-set-aside contract is scheduled for completion by July 29, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJS42Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors valued at $9,669.60, with completion scheduled for September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies and medications to federal defense and healthcare systems. As a established vendor in the DLA Medical Supply Chain, the company has demonstrated capability to meet federal procurement requirements across a diverse portfolio of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This award reflects the company's ongoing role in supporting military and veteran healthcare procurement through flexible contract vehicles designed to address dynamic federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 8/29/25 |